Hims Stock Catapults 126% As Obesity-Drug Wars Rage On Amid FDA Scrutiny

Hims & Hers Health (HIMS) has formed a cup-with-handle base that offers a buy point at 60.55. The stock had surged 126% year-to-date, as of Monday, according to IBD MarketSurge. Hims stock is Tuesday's selection for IBD 50 Stocks To Watch. This is an early-stage base that can net higher gains that later ones do. Hims & Hers Health makes… Related news Breakout Stocks Watch: What Looms For October? 10/01/2025As October gets underway with market indexes near record highs, these stocks to watch highlight rules ...